Banco Bilbao Vizcaya Argentaria S.A. Sells 307 Shares of Mettler-Toledo International, Inc. $MTD

Key Points

• Banco Bilbao Vizcaya Argentaria S.A. reduced its holdings in Mettler-Toledo International by 3.3% in the first quarter, now owning 8,862 shares valued at approximately $10.45 million.
• Insiders have sold a total of 2,589 shares of Mettler-Toledo International stock in the last three months, valued at $3.21 million, indicating a significant decrease in their ownership.
• Mettler-Toledo International reported an EPS of $10.09 for the last quarter, exceeding expectations and showing a revenue increase of 3.9% year over year.

Banco Bilbao Vizcaya Argentaria S.A. cut its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 3.3% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 8,862 shares of the medical instruments supplier's stock after selling 307 shares during the quarter. Banco Bilbao Vizcaya Argentaria S.A.'s holdings in Mettler-Toledo International were worth $10,447,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Vanguard Group Inc. increased its position in Mettler-Toledo International by 1.2% in the first quarter. Vanguard Group Inc. now owns 2,543,365 shares of the medical instruments supplier's stock worth $3,003,485,000 after purchasing an additional 30,535 shares during the period. Price T Rowe Associates Inc. MD grew its position in shares of Mettler-Toledo International by 6.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 455,739 shares of the medical instruments supplier's stock worth $557,680,000 after buying an additional 25,873 shares during the period. GAMMA Investing LLC lifted its holdings in shares of Mettler-Toledo International by 131,246.3% during the 1st quarter. GAMMA Investing LLC now owns 386,158 shares of the medical instruments supplier's stock valued at $456,018,000 after purchasing an additional 385,864 shares in the last quarter. T. Rowe Price Investment Management Inc. lifted its holdings in shares of Mettler-Toledo International by 36.1% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 363,107 shares of the medical instruments supplier's stock valued at $444,327,000 after purchasing an additional 96,300 shares in the last quarter. Finally, Principal Financial Group Inc. lifted its holdings in shares of Mettler-Toledo International by 2.1% during the 1st quarter. Principal Financial Group Inc. now owns 280,319 shares of the medical instruments supplier's stock valued at $331,032,000 after purchasing an additional 5,756 shares in the last quarter. 95.07% of the stock is owned by institutional investors.

Insider Transactions at Mettler-Toledo International

In other news, Director Thomas P. Salice sold 1,062 shares of the company's stock in a transaction dated Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the completion of the transaction, the director directly owned 283 shares in the company, valued at approximately $368,154.70. This represents a 78.96% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Gerry Keller sold 165 shares of the company's stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total value of $215,925.60. Following the completion of the transaction, the insider owned 94 shares of the company's stock, valued at $123,012.16. The trade was a 63.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 2,889 shares of company stock valued at $3,603,054. Corporate insiders own 1.94% of the company's stock.

Mettler-Toledo International Trading Up 3.3%

NYSE MTD traded up $42.4310 during trading hours on Friday, hitting $1,320.4310. 114,639 shares of the company's stock were exchanged, compared to its average volume of 166,744. The stock has a 50-day simple moving average of $1,227.64 and a 200 day simple moving average of $1,189.10. The firm has a market cap of $27.20 billion, a price-to-earnings ratio of 33.44, a PEG ratio of 3.84 and a beta of 1.34. Mettler-Toledo International, Inc. has a 1-year low of $946.69 and a 1-year high of $1,521.01.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The business had revenue of $983.22 million for the quarter, compared to analyst estimates of $957.41 million. During the same quarter in the prior year, the company earned $9.65 earnings per share. The company's quarterly revenue was up 3.9% on a year-over-year basis. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, sell-side analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Analysts Set New Price Targets

MTD has been the topic of several research reports. Evercore ISI cut their target price on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating on the stock in a research note on Monday, August 4th. Jefferies Financial Group raised Mettler-Toledo International from an "underperform" rating to a "hold" rating and decreased their target price for the stock from $1,200.00 to $1,110.00 in a report on Monday, May 5th. UBS Group raised Mettler-Toledo International from a "neutral" rating to a "buy" rating and decreased their target price for the stock from $1,530.00 to $1,350.00 in a report on Tuesday, May 20th. Wall Street Zen lowered Mettler-Toledo International from a "buy" rating to a "hold" rating in a report on Monday, May 5th. Finally, Bank of America upped their target price on Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the company a "neutral" rating in a research report on Thursday, June 26th. Five research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat, Mettler-Toledo International currently has an average rating of "Moderate Buy" and an average price target of $1,311.11.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.